Press release
Investigation announced for Long-Term Investors in shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR)
An investigation on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares over potential wrongdoing.
Investors who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) and currently hold any of those NASDAQ: VYGR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Voyager Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Cambridge, MA based Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. Voyager Therapeutics, Inc. reported that its annual Total Revenue rose from $7.61 million in 2018 to $104.39 million in 2019, and that its normalized Loss declined from $88.28 million in 2018 to $43.59 million in 2019.
On October 12, 2020, Voyager Therapeutics, Inc. disclosed that it "has received feedback from the U.S. Food and Drug Administration (FDA) on the Investigational New Drug (IND) submission for VY-HTT01 for the treatment of Huntington's disease." Specifically, Voyager advised investors that it "has been notified that the IND was placed on clinical hold pending the resolution of certain chemistry, manufacturing and controls (CMC) matters."
Shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) declined on October 13, 2020 to $10.90 per share.
Those who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) here
News-ID: 2225466 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Voyager
Voyager Replaces VMware with Virtuozzo to Regain Control of Cloud Infrastructure
Virtuozzo, the alternative cloud platform built for service providers, today announced that New Zealand-based telecommunications and cloud provider Voyager has successfully transitioned from VMware to Virtuozzo Hybrid Infrastructure - reclaiming full control over its cloud platform, pricing, and customer experience.
A Strategic Shift Towards Simplicity and Sovereignty
Voyager, one of New Zealand's leading ISPs and cloud service providers, had long relied on VMware to deliver hyperconverged infrastructure and cloud services.…
The Healthy Voyager Launches Holistic Travel Supplement Line
Los Angeles, CA - The Healthy Voyager, a leading brand in travel and wellness, has announced the launch of their new Holistic Travel Supplement Product Line. With a mission to help travelers stay healthy and happy on the road, The Healthy Voyager has created a line of vegetarian, vegan, and gluten-free supplements that cater to all types of travelers. The products are made with the highest quality, clean ingredients, allowing…
NO-BOundaries Voyager 1 E-Bike Launched on Indiegogo
Elevate Your Ride with Style, Safety, and Innovation
Image: https://www.abnewswire.com/uploads/b31b033407f6168d86dfeb385d0b0fed.PNG
NO-BOundaries launched today on Indiegogo Voyager 1, an e-bike crafted over a meticulous two-year period by a dedicated team to transcend the conventional notion of e-bikes. The campaign describes this e-bike as "not only a mode of transportation but a statement piece reflecting the user's lifestyle and personality."
One of the key features of the Voyager 1 is its integrated 360 lighting system,…
Digital Currency Trading Platform Market is Booming Worldwide | Coinbase, Binanc …
Latest Study on Industrial Growth of Digital Currency Trading Platform Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Digital Currency Trading Platform market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the…
Investigation announced for Investors in shares of Voyager Therapeutics, Inc. (N …
Voyager Therapeutics, Inc. are under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Voyager Therapeutics, Inc. regarding its business, its prospects and its operations were materially false…
Ataxia Therapeutics Pipeline Analysis 2018 | Reata Pharmaceuticals, Inc., Voyage …
Ataxia is a type of movement disorder characterized by lack of muscle control or coordination of voluntary movements. Some of the symptoms observed in the patients with ataxia are poor coordination, change in speech, difficulty in swallowing, and unsteady walk.
Download the sample report @ https://www.pharmaproff.com/request-sample/1078
The disease causes include head injury; stroke; autoimmune diseases, such as sarcoidosis and multiple sclerosis; paraneoplastic syndromes; and viral infections. The disease is also found in…
